REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSION

大脑去甲肾上腺素能神经传递的调节

基本信息

  • 批准号:
    3486958
  • 负责人:
  • 金额:
    $ 17.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-05-01 至 1993-04-30
  • 项目状态:
    已结题

项目摘要

The purpose of the present proposal is to conduct basic research on the neurobiology and pharmacology of the central noradrenergic system, a brain system thought to play an important role in central responses to stress and in mechanisms of antidepressant drug action. Research on the behavioral functions of this system has been hampered by the lack of a suitable means to study the activity of its receptors in the brains of conscious, freely moving animals. Recent studies in our laboratory however have indicated that a new technique involving the detection by implanted microdialysis probes of increases in the level of the second messenger, cyclic AMP (cAMP), in the brain in vivo in response to infusion of catecholamines now makes possible the study of these receptors in the intact brain. The purpose of the proposed research is to further develop this technique and to use it to study the in vivo regulation of central noradrenergic receptor function by pharmacological processes which are related to various aspects of stress and depression. The first aim of the project is to determine the sensitivity of the microdialysis-cAMP method in detecting experimental alterations in brain receptor function and in detecting ongoing neurotransmission at these receptors. This will be accomplished a) by determining if the technique can detect the chronic desensitization and sensitization of cAMP responses to catecholamines caused by chronic administration of an antidepressant drug or a central noradrenergic lesion, and b) by determining if it can detect cAMP responses to endogenous norepinephrine released by various procedures including stress, amphetamine infusion and stimulation of the locus coeruleus. The second aim of the project is to utilize the microdialysis method to investigate physiological factors that modulate the output of noradrenergic receptors in vivo. The studies will focus on the adrenocortical system, a system known to be active during stress and thought to have regulatory effects on noradrenergic receptors and will determine if corticosterone alters the action of catecholamines on these receptors or protects them from desensitization during prolonged catecholamine exposure. The above research therefore has the potential for providing a new tool that will facilitate investigations of the role of the noradrenergic system in stress and antidepressant drug actions and of providing insight into the physiological regulation of noradrenergic receptors during stress and during psychopathological conditions in which the level of adrenocortical function is increased (e.g., endogenous depression).
本提案的目的是进行基础研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC A STONE其他文献

ERIC A STONE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC A STONE', 18)}}的其他基金

REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSION
大脑去甲肾上腺素能神经传递的调节
  • 批准号:
    3486961
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
ALPHA-1 ADRENERGIC SYSTEM IN ACTIVITY AND DEPRESSION
活跃和抑郁状态下的 ALPHA-1 肾上腺素能系统
  • 批准号:
    7172591
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSION
大脑去甲肾上腺素能神经传递的调节
  • 批准号:
    2246497
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
ALPHA-1 ADRENERGIC SYSTEM IN ACTIVITY AND DEPRESSION
活跃和抑郁状态下的 ALPHA-1 肾上腺素能系统
  • 批准号:
    7573469
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
ALPHA-1 ADRENERGIC SYSTEM IN ACTIVITY AND DEPRESSION
活跃和抑郁状态下的 ALPHA-1 肾上腺素能系统
  • 批准号:
    7736787
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSION
大脑去甲肾上腺素能神经传递的调节
  • 批准号:
    3486960
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSION
大脑去甲肾上腺素能神经传递的调节
  • 批准号:
    6476987
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSION
大脑去甲肾上腺素能神经传递的调节
  • 批准号:
    6679963
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
ALPHA-1 ADRENERGIC SYSTEM IN ACTIVITY AND DEPRESSION
活跃和抑郁状态下的 ALPHA-1 肾上腺素能系统
  • 批准号:
    7028188
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:
REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSION
大脑去甲肾上腺素能神经传递的调节
  • 批准号:
    2246493
  • 财政年份:
    1989
  • 资助金额:
    $ 17.47万
  • 项目类别:

相似海外基金

Relationship between neurotoxicity and the chemical structures of amphetamines
安非他明的神经毒性与化学结构的关系
  • 批准号:
    25860103
  • 财政年份:
    2013
  • 资助金额:
    $ 17.47万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for protein expression in amphetamines treated mouse heart : Challenge to the diagnosis for the sudden death of amphetamines abusers
寻找安非他明治疗小鼠心脏中的蛋白质表达:对安非他明滥用者猝死诊断的挑战
  • 批准号:
    22659138
  • 财政年份:
    2010
  • 资助金额:
    $ 17.47万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8312648
  • 财政年份:
    2010
  • 资助金额:
    $ 17.47万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8531900
  • 财政年份:
    2010
  • 资助金额:
    $ 17.47万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8715749
  • 财政年份:
    2010
  • 资助金额:
    $ 17.47万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8144930
  • 财政年份:
    2010
  • 资助金额:
    $ 17.47万
  • 项目类别:
Translational Genetics and Dopamine Signaling in Sensitivity to Amphetamines
安非他明敏感性中的转化遗传学和多巴胺信号传导
  • 批准号:
    7675601
  • 财政年份:
    2009
  • 资助金额:
    $ 17.47万
  • 项目类别:
Simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates and interaction in the rat
大鼠体内麻黄碱、安非他明、可卡因、可卡因代谢物和阿片类药物的同时测定及其相互作用
  • 批准号:
    17590585
  • 财政年份:
    2005
  • 资助金额:
    $ 17.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study for practical use of two chiral analyses of amphetamines by gas chromatography-mass spectrometry
气相色谱-质谱法对苯丙胺两种手性分析的实用化研究
  • 批准号:
    17590588
  • 财政年份:
    2005
  • 资助金额:
    $ 17.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
3,4-亚甲二氧基安非他明的临床药理学
  • 批准号:
    6870119
  • 财政年份:
    2004
  • 资助金额:
    $ 17.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了